Literature DB >> 401834

Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.

J A Kazmierowski, J I Gallin, H Y Reynolds.   

Abstract

Approximately 4 h after an initial bronchoalveolar lavage (BAL) of a primate's lung, an appreciable number of polymorphonuclear leukocytes (PMNs) were noted to accumulate in respiratory fluids when lavage was repeated. Whereas, alveolar macrophages (90%) and lymphocytes (7%) were the principal respiratory cells recovered initially from lavage fluid, later samples contained 45-90% PMNs To explain the observed ingress of PMNs into lung fluids, concentrated BAL fluid was tested for chemoattractant activity. Such fluid obtained 4 and 24 h after an initial lavage contained material that produced directed migration (chemotaxis) for PMNs and mononuclear cells isolated from peripheral blood of normal donors. Gel filtration chromatography of BAL disclosed two peaks of chemotactic activity in the effluent fractions. Material from the column with an estimated molecular weight of 15,000 daltons was chemotactic for both PMNs and mononuclear cells. Because it was susceptible to inactivation with antiserum against the fifth component of complement, resistant to heating, and unaffected by antiserum against C3, this factor was considered analogous to the cleavage product of the fifth component of complement. C5a. In addition chemotactic activity for PMNs only was contained in an effluent peak having a molecular weight of about 5,000 daltons. This material was heat labile but unaffected by antisera to complement components. To locate the possible source of these factors in respiratory fluid, in vitro cultures of alveolar macrophages were established. These cells, whether stimulated by phagocytosis of opsonized bacteria or merely by attachment to a glass surface, produced chemotactic material which had physical characteristics similar to the small molecular weight material in BAL. Moreover, it induced preferential chemotaxis for PMNs. Thus, in primate lungs, at least two chemotactic substances may generate an inflammatory response; one which is a fragment of the complement component C5 and another small molecular weight factor which is released from alveolar macrophages.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401834      PMCID: PMC333357          DOI: 10.1172/JCI108638

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

Review 1.  Leukotaxis and leukotactic disorders. A review.

Authors:  P A Ward
Journal:  Am J Pathol       Date:  1974-12       Impact factor: 4.307

2.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

3.  The J. Burns Amberson Lecture--in defense of the lung.

Authors:  G M Green
Journal:  Am Rev Respir Dis       Date:  1970-11

4.  Studies on chemotaxis. XI. Effect on neutrophils of lysosomal and other subcellular fractions from leukocytes.

Authors:  J F Borel; H U Keller; E Sorkin
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

5.  C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.

Authors:  P A Ward; J H Hill
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

6.  Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.

Authors:  R A Clark; H R Kimball
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

7.  Secretion of plasminogen activator by stimulated macrophages.

Authors:  J C Unkeless; S Gordon; E Reich
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

8.  In vitro synthesis and secretion of lysozyme by mononuclear phagocytes.

Authors:  S Gordon; J Todd; Z A Cohn
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

9.  Studies on the mechanism of endogenous pyrogen production. III. Human blood monocytes.

Authors:  P Bodel
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  55 in total

1.  Immunopathology of the lung: a review.

Authors:  K J Johnson; W E Chapman; P A Ward
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

2.  Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.

Authors:  T R Martin; G Raugi; T L Merritt; W R Henderson
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

3.  Differential in vivo effects of whole cigarette smoke exposure versus cigarette smoke extract on mouse ciliated tracheal epithelium.

Authors:  Margaret K Elliott; Joseph H Sisson; William W West; Todd A Wyatt
Journal:  Exp Lung Res       Date:  2006 Mar-Apr       Impact factor: 2.459

4.  Inhibition of the release of a neutrophil chemotactic factor from macrophages partially explains the anti-inflammatory action of glucocorticoids.

Authors:  F Q Cunha; A T Cacini; S H Ferreira
Journal:  Agents Actions       Date:  1986-01

5.  Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion.

Authors:  G E Souza; F Q Cunha; R Mello; S H Ferreira
Journal:  Agents Actions       Date:  1988-07

6.  Generation of C5a by phagocytic cells.

Authors:  Markus Huber-Lang; Ellen M Younkin; J Vidya Sarma; Niels Riedemann; Stephanie R McGuire; Kristina T Lu; Robin Kunkel; John G Younger; Firas S Zetoune; Peter A Ward
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

7.  Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  G W Hunninghake; J E Gadek; T J Lawley; R G Crystal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

8.  Cystic fibrosis ciliary dyskinesia substances and pulmonary disease. Effects of ciliary dyskinesia substances on neutrophil movement in vitro.

Authors:  G B Wilson; H H Fudenberg; M T Parise; E Floyd
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

9.  Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol.

Authors:  A Rudent; F Michel; C Labarre; A M Quero; R Zalisz; P Smets
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

10.  Diffuse alveolar damage in cats induced by nitrogen dioxide or feline calicivirus.

Authors:  J M Langloss; E A Hoover; D E Kahn
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.